SCHEMBL71795

SCHEMBL71795

c1cc(Nc2cnccn2)cc(-c2cnc3ccccn23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.53
CDK2 P24941 4/20 0.53
CDK1 P06493 1/20 0.49
CDK4 P11802 1/20 0.49
MIF P14174 1/20 0.48
PKM P14618 2/20 0.47
FLT3 P36888 1/20 0.45
PIK3CA P42336 2/20 0.44
KDR P35968 6/20 0.43
FGFR3 P22607 3/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA3 P34903 1/20 0.43
IKBKE Q14164 1/20 0.43
TBK1 Q9UHD2 1/20 0.43
IGF1R P08069 1/20 0.41
DYRK3 O43781 1/20 0.41
CCNT1 O60563 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK9 P50750 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL74774 0.85 CDK2 (0.53) IRAK4CDK2CDK1CDK4MIF
SCHEMBL72956 0.85 CDK2 (0.60) IRAK4CDK2CDK1CDK4MIF
SCHEMBL72363 0.83 IRAK4 (0.61) IRAK4CDK2CDK1CDK4MIF
SCHEMBL3592576 0.82 KDR (0.63) FLT3KDRFGFR3GABRG2GABRB3
SCHEMBL73961 0.80 IRAK4 (0.52) IRAK4CDK2CDK1CDK4MIF
SCHEMBL73095 0.78 PKM (0.53) IRAK4CDK2CDK1CDK4MIF
SCHEMBL2789410 0.78 KDR (0.56) FLT3KDR
SCHEMBL73153 0.75 CDK2 (0.58) IRAK4CDK2CDK1CDK4MIF
SCHEMBL73956 0.75 CDK2 (0.48) IRAK4CDK2CDK1CDK4MIF
Formic Acid SCHEMBL73159 0.75 IRAK4 (0.47) IRAK4CDK2CDK1CDK4MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed